) has received another order from the  US Department of Health and Human Services (HHS) for 22.5 million doses of bulk  H5N1 antigen for the US national stockpile of pre-pandemic vaccines. This is in  addition to the 5 million doses of H5N1 bulk antigen ordered by the HHS in  November 2006. 

News

GlaxoSmithKline (London, UK, www.gsk.com) has received another order from the US Department of Health and Human Services (HHS) for 22.5 million doses of bulk H5N1 antigen for the US national stockpile of pre-pandemic vaccines.